Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Trulieve Cannabis (TCNNF – Research Report), Rallybio (RLYB – Research Report) and Canopy Growth (CGC – Research Report).
Trulieve Cannabis (TCNNF)
In a report released today, Scott Fortune from Roth MKM maintained a Buy rating on Trulieve Cannabis, with a price target of $9.00. The company’s shares closed last Friday at $5.10, close to its 52-week low of $3.42.
According to TipRanks.com, Fortune is ranked #7742 out of 8643 analysts.
Trulieve Cannabis has an analyst consensus of Strong Buy, with a price target consensus of $11.91, a 140.4% upside from current levels. In a report released yesterday, Haywood also reiterated a Buy rating on the stock with a C$14.50 price target.
See Insiders’ Hot Stocks on TipRanks >>
Rallybio (RLYB)
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Rallybio. The company’s shares closed last Friday at $2.88, close to its 52-week low of $2.85.
According to TipRanks.com, Baral is a 5-star analyst with an average return of
Currently, the analyst consensus on Rallybio is a Strong Buy with an average price target of $15.67, implying a 417.2% upside from current levels. In a report released today, Wedbush also maintained a Buy rating on the stock with a $14.00 price target.
Canopy Growth (CGC)
Canaccord Genuity analyst Matt Bottomley maintained a Sell rating on Canopy Growth yesterday and set a price target of C$0.50. The company’s shares closed last Friday at $0.50, close to its 52-week low of $0.35.
According to TipRanks.com, Bottomley is ranked #606 out of 8643 analysts.
Canopy Growth has an analyst consensus of Moderate Sell, with a price target consensus of $0.87, a 61.1% upside from current levels. In a report issued on November 1, CIBC also maintained a Sell rating on the stock with a C$0.50 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TCNNF:
- Trulieve Reports Third Quarter 2023 Results Delivering Significant Cash Generation
- Rising High: Exclusive talk with venture capital firm Safe Supply
- Rising High: Exclusive talk with cannabis market research firm BDSA
- Bipartisan lawmakers refile marijuana legalization bill, Marijuana Moment says
- Rising High: Exclusive talk with cannabis lender FundCanna
